flavivirus
caus
agent
sever
diseas
dengu
yellow
fever
replic
machineri
use
viru
base
enzym
includ
methyltransferas
locat
ntermin
domain
protein
flavivir
methyltransferas
involv
last
two
step
mrna
cap
process
transfer
methyl
group
sadenosyllmethionin
onto
posit
cap
guanin
methyltransferas
ribos
posit
first
nucleotid
follow
cap
guanin
methyltransferas
rna
cap
process
crucial
mrna
stabil
protein
synthesi
viru
replic
essenti
function
make
methyltransferas
attract
target
design
antivir
drug
context
start
crystal
structur
wesselsbron
flaviviru
methyltransferas
elabor
mechanist
model
describ
proteinrna
interact
methyl
transfer
next
use
silico
dock
procedur
identifi
commerci
avail
compound
would
display
high
affin
methyltransferas
activ
site
best
candid
select
test
vitro
assay
effect
inhibit
methyltransferas
activ
wesselsbron
dengu
viru
dv
methyltransferas
result
combin
comput
experiment
screen
approach
led
identif
highpot
inhibitor
genu
flaviviru
compris
rna
virus
mani
import
human
pathogen
dengu
viru
dv
exampl
estim
infect
million
peopl
year
caus
death
guhasapir
schimmer
current
specif
antivir
drug
avail
flavivir
infect
develop
activ
field
research
recent
year
sampath
padmanabhan
flavivir
genom
consist
kb
decor
structur
strictli
conserv
terminu
abbrevi
rdrp
rna
depend
rna
polymeras
mtase
guanin
methyltransferas
mtase
methyltransferas
adomet
sadenosyllmethionin
adohci
sadenosyllhomocystein
wv
wesselsbron
viru
ns
nonstructur
protein
gmp
guanosin
monophosph
gtp
guanosin
triphosph
dv
dengu
viru
wnv
west
nile
viru
lb
put
low
affin
rna
bind
site
hb
high
affin
rna
bind
site
ata
aurintricarboxyl
acid
ppnd
disulfon
tetrasodium
salt
pmsf
phenylmethylsulphonyl
fluorid
tlc
thinlay
chromatographi
correspond
author
tel
fax
email
address
martinobolognesi
unimiit
bolognesi
gpppa
ome
grna
genom
encod
polyprotein
precursor
process
viral
cellular
proteas
three
structur
protein
seven
nonstructur
protein
involv
viru
replic
field
et
al
among
protein
multifunct
protein
particularli
import
viral
replic
ctermin
domain
endow
rnadepend
rna
polymeras
rdrp
activ
ntermin
domain
contain
sadenosyllmethionin
adomet
depend
methyltransferas
mtase
activ
mtase
domain
involv
last
two
step
cap
process
start
convers
triphosph
end
nascent
rna
diphosph
rna
triphosphatas
activ
follow
addit
gmp
unit
via
phosphodiest
bond
guanylyltransferas
activ
mtase
transfer
methyl
group
adomet
cap
guanin
success
ribos
oatom
first
rna
nucleotid
form
cap
cap
structur
respect
crystal
structur
mtase
domain
sever
virus
complex
adomet
sadenosyllhomocystein
coproduct
methyl
transfer
adohci
gtp
capanalogu
assenberg
et
al
bollati
et
al
egloff
et
al
egloff
et
al
taken
start
data
analysi
main
structur
mechanist
featur
relat
mtase
activ
sinc
flavivir
mtase
display
activ
ray
et
al
zhou
et
al
order
cap
rna
methyl
two
differ
site
nucleic
acid
substrat
must
adopt
two
distinct
bind
mode
rel
enzym
activ
site
particular
mani
structur
result
assenberg
et
al
bollati
et
al
egloff
et
al
egloff
et
al
show
small
cap
rna
analogu
bind
mtase
high
affin
bind
site
hb
suppos
held
methyl
contrari
structur
detail
distinct
bind
site
occupi
cap
rna
methyl
miss
structur
consider
howev
suggest
exist
secondari
put
low
affin
bind
site
lb
dong
et
al
mastrangelo
et
al
locat
posit
charg
region
close
adomet
bind
site
first
present
model
short
cap
rna
gpppagup
bound
lb
wesselsbron
viru
mtase
wv
mtase
use
explor
detail
proteinrna
interact
methyl
transfer
base
analysi
discuss
silico
search
allow
select
three
synthet
compound
predict
display
low
free
energi
bind
wv
mtase
compound
select
test
vitro
wv
mtase
dv
mtase
methyltransferas
activ
assay
result
combin
comput
experiment
screen
allow
us
identifi
aurintricarboxyl
acid
ata
potent
flavivir
mtase
inhibitor
known
date
inhibitori
effect
ata
discuss
basi
exist
model
flavivir
mtase
mechan
cap
methyl
sinc
flaviviru
mtase
shown
mutagenesi
crucial
viral
replic
zhou
et
al
shed
light
mtase
inhibit
may
prove
product
path
toward
develop
therapeut
life
threaten
flavivir
diseas
dong
et
al
b
virtual
librari
pharmacolog
activ
compound
lopac
use
dock
analysi
provid
sigmaaldrich
includ
commerci
avail
compound
wwwsigmaaldrichcom
adomet
purchas
new
england
biolab
compound
test
vitro
ata
nilutamid
disulfon
tetrasodium
salt
ppnd
sigmaaldrich
compound
dissolv
mm
h
mm
mm
naoh
ata
store
c
order
produc
mtase
model
suitabl
analysi
methyl
process
crystal
structur
wv
mtase
complex
adomet
hbsbound
small
cap
rna
analog
gpppg
solv
resolut
pdb
bollati
et
al
use
hydrogen
atom
comput
gasteig
charg
gasteig
marsili
ad
remov
hbsbound
rna
analog
maintain
adomet
cofactor
bound
protein
squar
grid
side
center
roughli
lb
region
step
size
point
goodford
subsequ
built
use
volum
explor
cap
rna
dock
search
short
cap
rna
gpppagup
molecul
built
use
program
ghemic
http
wwwbioinformaticsorgghem
seventi
genet
algorithm
search
perform
use
move
gpppagup
within
describ
grid
use
activ
torsion
ligand
molecul
individu
popul
gener
morri
et
al
search
produc
list
cap
rna
posit
within
explor
lb
volum
rank
mean
estim
free
energi
bind
g
vari
kcalmol
among
four
best
g
valu
kcalmol
rang
model
cap
guanin
atom
closer
adomet
methyl
group
chosen
kcalmol
distanc
model
wv
mtasegpppagup
use
start
structur
molecular
dynam
md
simul
perform
use
program
gromac
van
der
spoel
et
al
briefli
protein
adomet
dock
cap
rna
gpppagup
enclos
box
fill
water
molecul
cl
ion
charg
equilibr
use
gromac
forc
field
correct
mark
et
al
energi
minim
steepest
descent
algorithm
system
equilibr
k
ps
k
ps
md
simul
carri
time
step
fs
use
leapfrog
algorithm
period
boundari
condit
electrostat
interact
treat
fast
particlemesh
ewald
algorithm
van
der
waal
interact
cutoff
simul
perform
fix
k
p
atm
use
berendsen
coupl
berendsen
et
al
structur
produc
ns
use
final
model
analysi
proteinrna
interact
softwar
packag
morri
et
al
use
dock
search
use
compound
lopac
librari
python
molecul
viewer
mgltool
packag
http
wwwmgltoolsscrippsedu
analyz
data
dock
model
atom
coordin
wv
mtase
complex
adomet
gpppg
chosen
pdb
bollati
et
al
keep
protein
adomet
molecul
remov
water
capanalogu
hydrogen
atom
comput
gasteig
charg
ad
use
program
gasteig
marsili
protein
model
use
build
discret
grid
within
box
dimens
step
size
point
goodford
compound
dock
search
search
ie
grid
center
posit
center
wide
crevic
locat
adomet
bind
site
rna
hb
precis
residu
way
protein
activ
site
methyl
transfer
adomet
occur
complet
includ
search
grid
chosen
twenti
genet
algorithm
search
run
use
compound
lopac
librari
individu
popul
gener
morri
et
al
gpppac
rna
substrat
use
mtase
assay
synthes
incub
dna
oligonucleotid
ccccgggtct
bacteriophag
dna
primas
presenc
gpppa
ctp
describ
reaction
product
obtain
h
incub
period
purifi
revers
phase
chromatographi
hplc
collect
peak
correspond
gpppac
describ
rna
substrat
use
mtase
assay
correspond
authent
termin
nucleotid
dv
genom
dv
rna
obtain
follow
utr
dv
serotyp
new
guinea
c
strain
amplifi
pcr
use
primer
cgggatcccagtaatacgactcactattagttgttagtctacgtggacc
ggaattcggtggtgcagatgaacttcag
clone
fermenta
plasmid
use
standard
restrictionlig
procedur
gener
plasmid
rna
transcript
templat
synthes
pcr
amplif
perform
plasmid
use
primer
ggtggtgcagatgaacttcaggg
pcr
reaction
product
purifi
agaros
gel
use
qiaquick
gel
extract
kit
qiagen
dv
rna
substrat
gener
vitro
transcript
use
megashortscript
rna
polymeras
ambion
recogn
class
ii
promot
underlin
primer
present
pcr
templat
initi
rna
synthesi
pppag
coleman
et
al
dnase
ambion
treatment
purif
rneasi
mini
kit
qiagen
dv
rna
incub
h
c
vaccinia
viru
cap
enzym
epicentr
madison
wi
presenc
ci
p
gtp
perkinelm
boston
unit
inorgan
pyrophosphatas
sigmaaldrich
radiolabel
cap
dv
rna
purifi
rneasi
mini
kit
qiagen
activ
wv
dv
mtase
test
incub
purifi
protein
small
cap
rna
substrat
gpppac
presenc
h
adomet
describ
luzhkov
et
al
briefli
mtase
activ
assay
perform
l
sampl
contain
mm
tri
ph
mm
dtt
adomet
ci
h
adomet
amersham
bioscienc
wv
dv
mtase
rna
substrat
gpppac
recombin
wv
dv
mtase
produc
previous
describ
bollati
et
al
egloff
et
al
respect
enzym
premix
inhibitor
candid
reaction
start
premix
adomet
rna
substrat
first
test
seri
two
differ
final
inhibitor
concentr
use
determin
ic
valu
ata
compound
concentr
rang
test
reaction
incub
c
two
sampl
spot
immedi
mix
h
plate
contain
l
ice
cold
adohci
stop
reaction
sampl
transfer
glassfibr
filtermat
deae
filtermat
wallac
filtermat
harvest
packard
instrument
filtermat
wash
twice
ammonium
format
ph
twice
water
ethanol
dri
transfer
sampl
bag
liquid
scintil
fluid
ad
methyl
rna
substrat
measur
count
per
minut
cpm
use
wallac
microbeta
trilux
liquid
scintil
counter
ic
inhibitor
concentr
activ
valu
inhibitor
compound
determin
two
independ
experi
done
data
adjust
logist
doserespons
function
activ
ic
b
b
correspond
slope
factor
determin
slope
curv
delean
et
al
mtase
inhibit
assay
perform
mm
tri
ph
mm
nacl
mm
dtt
adomet
pmol
wv
dv
mtase
approxim
g
radiolabel
cap
dv
rna
l
reaction
volum
c
min
h
describ
mtase
assay
enzym
premix
inhibitor
candid
reaction
start
premix
adomet
rna
substrat
reaction
stop
heat
c
min
sampl
treat
overnight
proteinas
k
gl
proteinas
k
inactiv
heat
c
min
addit
mm
pmsf
methyl
reaction
mixtur
subsequ
digest
h
nucleas
digest
product
separ
polyethyleneimin
cellulos
thinlay
chromatographi
tlc
plate
macherey
nagel
use
nh
mobil
phase
dri
tlc
plate
nonlabel
standard
visual
uv
shadow
cap
structur
releas
nucleas
visual
use
phosphorimag
fluoresc
imag
analyz
fuji
quantif
perform
use
imag
gaug
softwar
order
analyz
mtase
region
propos
act
cap
rna
bind
site
methyl
lb
produc
dock
model
wv
mtase
shortcap
rna
gpppagup
see
section
subsequ
relax
model
ns
md
simul
simul
start
energi
system
kcalmol
reach
mean
valu
kcalmol
ps
remain
constant
thereaft
energi
root
mean
squar
deviat
rmsd
kcalmol
wv
mtase
secondari
structur
element
thoroughli
conserv
simul
exclus
part
ctermin
amino
acid
ctermin
fluctuat
agreement
observ
sever
flavivir
mtase
crystal
structur
ctermin
helix
locat
electron
densiti
display
high
bfactor
valu
bollati
et
al
fact
ctermin
helix
present
fig
model
mtasecap
rna
interact
lb
ns
molecular
dynam
protein
shown
white
surfac
adomet
yellow
cap
rna
red
five
residu
shown
dong
et
al
impair
methyltransferas
activ
blue
b
closer
view
lb
region
show
key
rna
recognit
residu
adomet
shade
area
highlight
volum
occupi
cap
rna
analog
gpppagup
interpret
refer
color
figur
legend
reader
refer
web
version
articl
wv
mtase
shown
part
rdrp
domain
west
nile
viru
wnv
dv
yap
et
al
group
structur
produc
md
cluster
accord
similar
may
help
detect
time
evolut
protein
toward
new
overal
conform
perform
analys
chose
discard
nand
ctermin
residu
protein
focus
amino
acid
thu
ignor
motil
protein
termin
use
cutoff
rmsd
cluster
differ
structur
observ
md
time
evolut
limit
found
structur
gener
simul
could
group
nine
differ
cluster
last
cluster
contain
state
produc
first
ps
suggest
earli
stabil
protein
scaffold
simul
cluster
analysi
carri
investig
structur
evolut
cap
rna
simul
cutoff
cap
rna
cluster
produc
last
one
start
ns
last
end
simul
ns
ns
interv
interpret
time
need
rna
reach
stabl
conform
follow
interact
protein
start
dock
model
rmsd
valu
calcul
simul
structur
vs
crystal
structur
md
reach
mean
valu
rmsd
ns
equilibr
protein
region
higher
motil
simul
consid
amino
acid
hb
ntermin
helixloophelix
motif
amino
acid
loop
amino
acid
shown
highli
mobil
also
crystal
structur
propos
involv
adomet
bindingadohci
releas
methyl
transfer
rna
bollati
et
al
structur
produc
ns
md
use
analyz
wv
mtasecap
rna
interact
lb
region
model
fig
b
cap
guanin
locat
close
adomet
residu
residu
found
interact
cap
rna
recent
shown
point
mutat
amino
acid
dramat
inhibit
methyl
transfer
activ
wnv
mtase
dong
et
al
particular
seven
amino
acid
whose
mutat
ala
reduc
mention
activ
identifi
context
analyz
role
interfac
residu
indic
wv
mtaserna
simul
model
propos
neglect
fact
two
residu
spatial
close
partli
buri
protein
core
expect
mutat
ala
might
critic
alter
correct
mtase
fold
moreov
locat
floor
mtase
catalyt
tetrad
region
kdke
wv
mtase
hydrogen
bond
thu
may
play
crucial
role
stabil
catalyt
residu
result
wv
mtaserna
interact
model
focus
five
remain
residu
fig
differ
criteria
explor
past
discoveri
effect
mtase
inhibitor
dong
et
al
b
particular
search
compound
compet
adomet
bind
consid
one
promis
approach
luzhkov
et
al
ray
et
al
adomet
princip
biolog
methyl
donor
cell
normal
condit
human
g
adomet
gener
per
day
use
transmethyl
reaction
wherebi
methyl
group
ad
differ
compound
adomet
convert
adohci
lu
thu
specul
mtase
inhibit
base
adomet
competit
might
particularli
difficult
achiev
moreov
sinc
mani
distinct
enzym
requir
adomet
cofactor
adomet
mimet
compound
like
sinefungin
ic
wnv
mtase
dong
et
al
may
turn
gener
toxic
therefor
differ
inhibitor
search
strategi
could
principl
direct
toward
blockag
mtase
hb
howev
class
inhibitori
molecul
would
like
provid
inhibit
mtase
reaction
mtase
activ
therefor
design
new
inhibitor
decid
target
activ
site
enzym
bound
adomet
cofactor
enzymat
reaction
transfer
methyl
group
adomet
rna
two
mtase
reaction
requir
precis
locat
rna
substrat
activ
site
locat
dictat
posit
adomet
transferr
methyl
group
consider
suggest
small
ligand
bind
protein
locat
close
insid
cofactorbind
site
would
potenti
impair
methyl
reaction
moreov
ligand
could
interact
directli
adomet
adohci
potenti
slow
releas
latter
protein
enzym
turnov
target
ligand
dock
thu
select
activ
site
region
locat
adomet
bind
site
hb
lb
fig
explor
simul
model
describ
select
region
explor
use
librari
small
molecul
lopac
librari
describ
section
search
produc
list
compound
predict
free
energi
bind
g
rang
kcalmol
top
three
rank
compound
produc
dock
search
nilutamid
ppnd
ata
fig
display
lowest
bind
energi
g
kcalmol
respect
use
vitro
test
mtase
inhibitori
activ
fig
inhibitori
effect
three
best
binder
select
silico
determin
dv
mtase
wv
mtase
mtase
activ
purpos
first
test
inhibit
ata
nilutamid
ppnd
measur
transfer
h
methyl
group
short
gpppac
substrat
yield
gpppa
ome
c
fig
show
wherea
nilutamid
ppdn
display
effici
inhibit
flavivir
mtase
select
concentr
ata
strongli
inhibit
mtase
even
therefor
determin
ic
valu
ata
concentr
rang
inhibit
nitulamin
ppnd
ata
two
concentr
inhibitor
candid
test
control
reaction
carri
absenc
inhibitor
candid
methyl
transfer
rna
substrat
stop
h
detect
use
filterbind
assay
measur
amount
radioact
cpm
transfer
rna
substrat
mtase
activ
arbitrarili
attribut
mtase
activ
absenc
inhibitor
bar
graph
present
result
three
independ
experi
b
inhibit
wv
dv
mtase
activ
use
increas
concentr
ata
nm
valu
determin
fit
dose
respons
curv
describ
section
reaction
carri
triplic
standard
deviat
plot
consid
strongest
inhibitor
flavivir
mtase
activ
known
date
flavivir
mtase
also
mediat
guanin
methyl
enzymat
reaction
perform
presenc
rna
substrat
compris
nucleotid
includ
stem
loop
structur
conserv
untransl
region
flaviviru
genom
ray
et
al
dong
et
al
order
determin
whether
ata
inhibit
flavivir
mtase
activ
synthes
rna
correspond
first
nucleotid
dv
genom
dv
rna
use
polymeras
cap
rna
addit
p
gtp
use
vaccinia
viru
guanylyltransferas
see
section
expect
dv
rna
would
appropri
substrat
wv
mtase
first
three
nucleotid
cap
rna
genom
virus
gpppagu
shown
besid
presenc
stem
loop
structur
conserv
second
third
nucleotid
especi
import
specif
mtase
activ
cap
dv
rna
incub
wv
mtase
presenc
increas
ata
concentr
reaction
product
analyz
nucleas
digest
tlc
autoradiographi
fig
show
absenc
wv
mtase
ctl
radiolabel
gpppa
releas
substrat
rna
nucleas
detect
expect
posit
presenc
wv
mtase
ctl
almost
gpppa
convert
new
product
comigr
gpppa
cap
analog
standardli
visual
uv
shad
two
control
carri
one
without
enzym
one
without
ata
molecular
weight
marker
visual
uv
shadow
b
determin
valu
ata
mtase
activ
wv
dv
mtase
percentag
activ
determin
quantif
gpppa
gpppa
valu
determin
fit
doserespons
curv
fig
owe
longer
incub
time
part
gpppa
methyl
gpppa
ome
shown
conclud
optim
reaction
condit
rna
correspond
first
nucleotid
dv
genom
good
substrat
specif
follow
mtase
activ
wv
mtase
next
determin
ic
valu
ata
inhibit
mtase
quantifi
gpppa
convers
gpppa
presenc
increas
ata
concentr
min
linear
phase
mtase
reaction
ata
inhibit
wv
mtase
activ
higher
concentr
observ
mtase
assay
ic
valu
compar
respect
shown
fig
ata
moder
inhibit
dv
mtase
activ
ic
valu
compar
ic
inhibit
dv
mtase
activ
thu
result
indic
ata
inhibit
mtase
activ
dv
wv
minor
extent
compar
mtase
activ
analysi
complex
model
obtain
dock
ata
wv
mtase
show
inhibitor
molecul
face
adomet
bind
site
fig
particular
ata
interact
mani
posit
charg
amino
acid
conserv
flaviviru
mtase
mostli
conserv
establish
hydrogen
bond
atom
adomet
ribos
contribut
cofactor
stabil
bind
pocket
interestingli
dock
model
indic
hydrogen
bond
ata
hydroxyl
group
side
chain
part
conserv
catalyt
tetrad
kdke
support
mtase
activ
thu
ata
bound
site
predict
dock
md
may
impair
correct
locat
rna
catalyt
site
steric
hindranc
interact
residu
involv
rna
recognit
result
report
show
basic
hypothes
flavivir
mtase
mechan
action
specif
deepen
understand
role
play
lb
could
effici
lead
propos
novel
bind
site
inhibitor
start
wv
mtase
crystal
structur
bollati
et
al
propos
model
proteinrna
interact
methyl
activ
crystal
structur
avail
far
use
propos
lb
rna
bind
site
select
three
compound
screen
mean
dock
analysi
silico
among
three
best
ligand
identifi
show
vitro
inhibitori
assay
ata
potent
inhibitor
flavivir
mtase
activ
wv
dv
ata
also
inhibit
wv
dv
mtase
activ
longer
rna
minor
extent
effici
inhibitori
action
ata
mtase
activ
consist
specif
interact
residu
indic
dock
inde
residu
previous
shown
import
mtase
activ
mtase
activ
zhou
et
al
moreov
sinc
mtase
mtase
assay
perform
rna
differ
length
possibl
differ
ic
valu
found
reflect
differ
affin
rna
substrat
inhibit
assay
taken
togeth
result
demonstr
inhibitori
capabl
ata
micromolar
rang
support
hypothesi
lb
adjac
mtasebound
adomet
target
new
inhibitori
site
may
suitabl
drug
lead
develop
interestingli
ata
report
inhibit
replic
differ
kind
virus
includ
human
immunodefici
viru
hiv
schol
et
al
influenza
viru
hung
et
al
vaccinia
viru
myskiw
et
al
moreov
recent
patent
indic
possibl
inhibitori
role
ata
sar
corona
viru
patent
result
indic
gener
activ
ata
flavivirus
also
report
author
patent
howev
propos
model
explain
report
antivir
efficaci
result
present
suggest
specif
molecular
target
possibl
mechan
inhibitori
activ
ata
flavivirus
cautionari
note
recal
ata
gener
report
literatur
nonspecif
inhibitor
sever
differ
enzym
binastein
tritton
fact
ata
appear
abl
impair
differ
kind
proteinnucleotid
interact
therefor
may
also
play
yet
unknown
role
inhibit
viral
replic
process
beyond
rna
cap
moreov
consid
ata
capabl
inhibit
proteinnucleotid
interact
exclud
differentfurth
effect
even
mtase
blockag
hb
site
key
rna
bind
site
methyl
effect
result
decreas
protein
affin
adomet
